A UCLA Health research team has helped define and characterize a rare bowel obstruction that affects premature infants, known ...

Cystic fibrosis patients rarely used to see age 30. Now, with this Iowa doctor's work, people are living well into their 80s ...

One of this year's coveted Lasker Awards went to three scientists who helped invent a life-saving treatment for cystic fibrosis, a genetic disease.

González, Paul Negulescu, and Michael Welsh received the 2025 Lasker Clinical Medical Research Award for the development of a ...

Background: In patients with cystic fibrosis (pwCF) acid suppression therapy, gastrointestinal dysmotility, and post-operative bowel status, may predispose to the development of small intestinal ...

LAFAYETTE, La. (KLFY) — A skeet shoot will be held in an effort to raise money and awareness for the Cystic Fibrosis Foundation. The Cystic Fibrosis Foundation is a non‑profit organization dedicated ...

A new wireless and wearable device developed by Northwestern Medicine scientists, in collaboration with Northwestern University spinout company, Epicore Biosystems, measures specific biomarkers in a ...

Treatment with brensocatib 10 mg and 25 mg significantly reduced the annual rate of pulmonary exacerbations in patients with NCFB. The Food and Drug Administration (FDA) has approved Brinsupri ™ ...

Brinsupri (brensocatib) is a new oral medicine approved to treat a long-term lung disease known as non-cystic fibrosis bronchiectasis (NCFB) in adults and children ages 12 or older. It works by ...

Insmed has won U.S. Food and Drug Administration approval of Brinsupri as the first and only treatment for the chronic lung disease non-cystic fibrosis bronchiectasis. Insmed on Tuesday said the FDA ...

BRIDGEWATER, N.J., Aug. 12, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform ...